Wedbush reaffirmed their outperform rating on shares of Gossamer Bio (NASDAQ:GOSS – Free Report) in a report released on Wednesday, Benzinga reports. The brokerage currently has a $6.00 price target on the stock. Wedbush also issued estimates for Gossamer Bio’s Q1 2024 earnings at ($0.17) EPS, Q2 2024 earnings at ($0.17) EPS, Q3 2024 earnings […]
Wedbush restated their outperform rating on shares of Gossamer Bio (NASDAQ:GOSS – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. The firm currently has a $6.00 price target on the stock. Wedbush also issued estimates for Gossamer Bio’s Q1 2024 earnings at ($0.17) EPS, Q2 2024 earnings at ($0.17) […]
HC Wainwright Reiterates "Buy" Rating for Gossamer Bio (NASDAQ:GOSS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Gossamer Bio (NASDAQ:GOSS) Given New $8.00 Price Target at The Goldman Sachs Group theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Gossamer Bio (NASDAQ:GOSS) Earns "Buy" Rating from HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.